The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, September 24, 2020
ARCA has submitted an IND application with the FDA under the CTAP to evaluate AB201 for the treatment of patients hospitalized with COVID-19.
read more
Thursday, September 24, 2020
Ampio announces the receipt of an IND from the FDA, allowing the Company to proceed with clinical trials for the use of Ampion as an inhalation ...
read more
Friday, September 25, 2020
Vaccinex announced topline results from the early manifest treatment arm of the Phase 2 double-blind, placebo-controlled SIGNAL trial of its lead ...
read more
Friday, September 25, 2020
NeoMatrix announced positive topline data from its Phase 1 clinical trial of NMT-cP12, its lead candidate for the treatment of severe burns.
read more
Monday, September 28, 2020
ENTEROME announced the first patient has been dosed in a trial of sibofimloc in patients with Crohn's disease.
read more
Monday, September 28, 2020
DURECT has dosed the first patient in its randomized, double-blind, placebo-controlled, multi-center Phase 2 study to evaluate the safety and efficacy...
read more
Tuesday, September 29, 2020
The FDA issued an EUA for the first serology POC test for COVID-19.
read more
Tuesday, September 29, 2020
The FDA has approved Nucala for adults and children aged 12 years and older with HES for six months or longer without another identifiable non-blood ...
read more
Tuesday, September 29, 2020
Eiger announced results of an investigator sponsored study of Peginterferon Lambda-1a in outpatients with mild and uncomplicated COVID-19.
read more
Wednesday, September 30, 2020
JanOne has started production of JAN101 under cGMP for the company's anticipated Phase 2b trials to treat PAD and as a potential treatment for Covid-...
read more
Wednesday, September 30, 2020
Cipla has received final approval for its ANDA for Dimethyl Fumarate DR Capsules from the FDA.
read more
Wednesday, September 30, 2020
CSL Behring announced the FDA has approved an expanded indication for HAEGARDA for routine prophylaxis to prevent HAE attacks in patients 6 years of ...
read more
Wednesday, September 30, 2020
Shionogi announced the FDA has approved a sNDA for FETROJA for HABP/VABP caused by Gram-negative microorganisms.
read more
Wednesday, September 30, 2020
Enesi Pharma has reported positive top-line results from a study evaluating the immune responses generated by an ImplaVax-enabled unit solid-dose ...
read more
Ovid announced results from the ARCADE and ENDYMION studies of soticlestat in patients with developmental and epileptic encephalopathies.
read more